These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 34323189)
1. Advancement of Prodrug Approaches for Nucleotide Antiviral Agents. Li Y; Yang B; Quan Y; Li Z Curr Top Med Chem; 2021; 21(32):2909-2927. PubMed ID: 34323189 [TBL] [Abstract][Full Text] [Related]
2. Optimization of the Prodrug Moiety of Remdesivir to Improve Lung Exposure/Selectivity and Enhance Anti-SARS-CoV-2 Activity. Hu H; Mady Traore MD; Li R; Yuan H; He M; Wen B; Gao W; Jonsson CB; Fitzpatrick EA; Sun D J Med Chem; 2022 Sep; 65(18):12044-12054. PubMed ID: 36070561 [TBL] [Abstract][Full Text] [Related]
3. An overview of ProTide technology and its implications to drug discovery. Serpi M; Pertusati F Expert Opin Drug Discov; 2021 Oct; 16(10):1149-1161. PubMed ID: 33985395 [No Abstract] [Full Text] [Related]
4. Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years. Sinokrot H; Smerat T; Najjar A; Karaman R Molecules; 2017 Oct; 22(10):. PubMed ID: 29035325 [No Abstract] [Full Text] [Related]
5. Application of kinase bypass strategies to nucleoside antivirals. Ray AS; Hostetler KY Antiviral Res; 2011 Nov; 92(2):277-91. PubMed ID: 21878354 [TBL] [Abstract][Full Text] [Related]
6. Nucleoside diphosphate and triphosphate prodrugs - An unsolvable task? Meier C Antivir Chem Chemother; 2017 Dec; 25(3):69-82. PubMed ID: 29096525 [TBL] [Abstract][Full Text] [Related]
7. The ProTide Prodrug Technology: From the Concept to the Clinic. Mehellou Y; Rattan HS; Balzarini J J Med Chem; 2018 Mar; 61(6):2211-2226. PubMed ID: 28792763 [TBL] [Abstract][Full Text] [Related]
8. Prodrugs of Nucleoside 5'-Monophosphate Analogues: Overview of the Recent Literature Concerning their Synthesis and Applications. Roy B; Navarro V; Peyrottes S Curr Med Chem; 2023; 30(11):1256-1303. PubMed ID: 36093825 [TBL] [Abstract][Full Text] [Related]
9. Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 That Exhibits Antiviral Efficacy in SARS-CoV-2-Infected African Green Monkeys. Mackman RL; Kalla RV; Babusis D; Pitts J; Barrett KT; Chun K; Du Pont V; Rodriguez L; Moshiri J; Xu Y; Lee M; Lee G; Bleier B; Nguyen AQ; O'Keefe BM; Ambrosi A; Cook M; Yu J; Dempah KE; Bunyan E; Riola NC; Lu X; Liu R; Davie A; Hsiang TY; Dearing J; Vermillion M; Gale M; Niedziela-Majka A; Feng JY; Hedskog C; Bilello JP; Subramanian R; Cihlar T J Med Chem; 2023 Sep; 66(17):11701-11717. PubMed ID: 37596939 [TBL] [Abstract][Full Text] [Related]
10. The ProTides Boom. Mehellou Y ChemMedChem; 2016 Jun; 11(11):1114-6. PubMed ID: 27159529 [TBL] [Abstract][Full Text] [Related]
11. Phosphoramidates and phosphonamidates (ProTides) with antiviral activity. Slusarczyk M; Serpi M; Pertusati F Antivir Chem Chemother; 2018; 26():2040206618775243. PubMed ID: 29792071 [TBL] [Abstract][Full Text] [Related]
12. Tissue-Specific Proteomics Analysis of Anti-COVID-19 Nucleoside and Nucleotide Prodrug-Activating Enzymes Provides Insights into the Optimization of Prodrug Design and Pharmacotherapy Strategy. Li J; Liu S; Shi J; Wang X; Xue Y; Zhu HJ ACS Pharmacol Transl Sci; 2021 Apr; 4(2):870-887. PubMed ID: 33855276 [TBL] [Abstract][Full Text] [Related]
13. Nucleotide prodrugs for the treatment of HCV infection. Sofia MJ Adv Pharmacol; 2013; 67():39-73. PubMed ID: 23885998 [TBL] [Abstract][Full Text] [Related]
20. Broad-spectrum prodrugs with anti-SARS-CoV-2 activities: Strategies, benefits, and challenges. Wang Z; Yang L J Med Virol; 2022 Apr; 94(4):1373-1390. PubMed ID: 34897729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]